Key result
Overexpression of a constitutively active PKG mutant reduced percent stenosis in porcine coronary arteries with in-stent restenosis compared to control (45% vs 70%, P<0.05).
Why the study?
Does overexpression of a constitutively active PKG mutant reduce neointima formation and in-stent restenosis in animal models of vascular injury?
Does overexpression of a constitutively active PKG mutant reduce neointima formation and in-stent restenosis in animal models of vascular injury?
Absolute Event Rate: 45% vs 70%
p-value: p=<0.05
Gene transfer of a constitutively active PKG mutant reduces neointima formation and in-stent restenosis in animal models, suggesting a potential therapeutic strategy for vasculoproliferative disorders.
No takes yet. Share an insight, caveat, or question.
Warrants PKG-targeted exploration in restenosis models; leaves open human translation pending further studies.
Sinnaeve et al. (2002) studied Neointima formation and in-stent restenosis (n=44). Constitutively active PKG mutant (AdPKGcat) vs. Wild-type PKG (AdPKG) or control adenovirus was evaluated on Percent stenosis in porcine coronary arteries (p=<0.05). Overexpression of a constitutively active PKG mutant reduced percent stenosis in porcine coronary arteries with in-stent restenosis compared to control (45% vs 70%, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: